- Treatment with once‐weekly alendronate oral jelly compared with once‐weekly alendronate oral tablet for Japanese patients with primary osteoporosis: An open‐label, prospective, observational study
Nobukazu Okimoto et al, 2019, Health Science Reports CrossRef - Study on the Mechanism of Compound Kidney-Invigorating Granule for Osteoporosis based on Network Pharmacology and Experimental Verification
Hao Lv et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef - The Mechanism of Action of Taurine in the Digestive System
Reza Heidari et al, 2023, Taurine and the Mitochondrion: Applications in the Pharmacotherapy of Human Diseases CrossRef - The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women
D. Sanchez-Rodriguez et al, 2020, Maturitas CrossRef - Deprescribing in Older Adults With Cancer and Limited Life Expectancy: An Integrative Review
Edwin J. Brokaar et al, 2022, American Journal of Hospice and Palliative Medicine® CrossRef - Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials
Zsuzsa Réka Dömötör et al, 2020, Frontiers in Endocrinology CrossRef